Projects per year
Projects 2005 2024
- 1 - 50 out of 56 results
- Status, start date (descending)
Active
A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of the Combination Therapy of SCY-078 with Voriconazole in Patients with Invasive Pulmonary Aspergillosis (SCYNERGIA)
3/29/19 → 3/30/24
Project: Research project
Invasive Pulmonary Aspergillosis
Double-Blind Method
Safety
Therapeutics
Voriconazole
A Phase III Randomized Placebo-Controlled Study to Examine the Efficacy and Safety of DAS181 for theTreatment of Lower Respiratory Tract Parainfluenza Infection in Immunocompromised Subjects
2/6/19 → 2/29/24
Project: Research project
Paramyxoviridae Infections
Respiratory Tract Infections
Placebos
Safety
Therapeutics
A Multi-center, Retrospective Study of Serious Infections Caused by Acinetobacter baumanniicalcoaceticusComplex
ENTASIS THERAPEUTICS HOLDINGS INC
11/25/18 → 11/30/23
Project: Research project
Acinetobacter Infections
Retrospective Studies
A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy andSafety of Pimodivir in Combination With the Standard-of-care Treatment in Adolescent, Adult, ElderlyHospitalized Patients With Influenza A Infection
JANSSEN RESEARCH & DEVELOPMENT, LLC
10/1/18 → 10/30/21
Project: Research project
Standard of Care
Human Influenza
Multicenter Studies
Placebos
Safety
A Phase 3, Multicenter, Randomized, Double-blind Study of the Efficacy and Safety ofRezafungin for Injection vs Intravenous Caspofungin Followed by Optional Oral Fluconazole Step-down inthe Treatment of Subjects with Candidemia and/or In
8/1/18 → 12/31/19
Project: Research project
caspofungin
Candidemia
Fluconazole
Double-Blind Method
Intravenous Injections
Aspergillosis
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Acute Myeloid Leukemia
Transplants
Therapeutics
A Phase 3, Multicenter, Randomized, Open-label, Active-c
SHIRE HUMAN GENETIC THERAPIES, INC.
1/1/17 → 12/31/20
Project: Research project
Labels
Survey of Bloodstream Infections in High Risk Neutropeni
University of Nebraska Medical Center
11/15/16 → 1/31/20
Project: Research project
Infection
Neoplasms
Surveys and Questionnaires
Mycoses
Safety
Therapeutics
Mucormycosis
Aspergillosis
Registries
Therapeutics
Triazoles
Registries
Fungi
A Phase 3, Multicenter, Randomized, Double-blind, Double
SHIRE HUMAN GENETIC THERAPIES, INC.
8/1/16 → 12/31/20
Project: Research project
Cytomegalovirus Infections
Hematopoietic Stem Cells
Transplants
Safety
valganciclovir
Observational Studies
Prospective Studies
Clinical Studies
cidofovir hexadecyloxypropyl ester
Natural History of Infection Caused by BK Virus (and oth
University of Alabama at Birmingham
9/28/13 → 12/31/19
Project: Research project
BK Virus
Pancreas
Kidney
Infection
Transplant Recipients
Herpes Zoster
Vaccines
Invasive Candidiasis
Critical Care
Placebos
Therapeutics
Clostridium Infections
Clostridium difficile
CB-183,315
Phase 4, Open-Label Pilot Study to Evaluate the Combinat
10/30/07 → 12/31/20
Project: Research project
Voriconazole
A Prospective, Randomized trial Comparing The Efficacy o
10/30/07 → 12/31/20
Project: Research project
anidulafungin
Therapeutics
Voriconazole
anidulafungin
Azoles
Finished
Clinical Performance of the Aptima CMV Quant Assay on the Panther System
3/13/19 → 10/25/19
Project: Research project
Targeted Clinical Research to Address Select Viral Infections
Fred Hutchinson Cancer Research Center
11/8/17 → 11/7/19
Project: Research project
Virus Diseases
Research
Mycobacterium avium Complex
Amikacin
Inhalation
Multicenter Studies
Lung
Human Influenza
Safety
Respiratory Syncytial Virus Infections
Randomized Controlled Trials
Lung
Transplant Recipients
GS-5806
Adenoviridae Infections
Historically Controlled Study
cidofovir hexadecyloxypropyl ester
Safety
Clinical Studies
SMT19969
Cytomegalovirus Infections
Randomized Controlled Trials
Placebos
Safety
AIC246
Antiviral Agents
Pharmacokinetics
Placebos
Transplants
Safety
Antiviral Agents
Pharmacokinetics
Placebos
Transplants
Safety
Adenoviridae
Multicenter Studies
Safety
cidofovir hexadecyloxypropyl ester
Herpes Zoster
Hematologic Neoplasms
Vaccines
A Randomized, Double-Blinded, Active-Controlled Study of
Green, J. S. & Young, J. H.
7/1/12 → 6/30/14
Project: Research project
Clostridium difficile
Diarrhea
CB-183,315
A Randomized, Placebo-Controlled, Multi-Site Phase 2 Stu
10/31/11 → 12/31/13
Project: Research project
Hematopoietic Stem Cell Transplantation
Adenoviridae
Placebos
Safety
cidofovir hexadecyloxypropyl ester
caspofungin
Candidemia
Candida
Double-Blind Method
Safety
Mycoses
Double-Blind Method
Fungi
Safety
Voriconazole
Aspergillosis
Mycoses
Fungi
Yeasts
Kidney
Suspensions
Pharmacokinetics
Safety
posaconazole
Invasive Fungal Infections
A Multicenter, Open-Label Study of CMX001 Treatment of S
11/30/10 → 12/31/12
Project: Research project
Viruses
cidofovir hexadecyloxypropyl ester
Antiviral Agents
Placebos
Safety
Pharmaceutical Preparations
Therapeutics
caspofungin
anidulafungin
Candida
Safety
Infection
A Randomized, Multicenter, Single Blinded, ParallelStudy
HOFFMANN-LA ROCHE PHARMACEUTICALS
12/28/09 → 12/31/12
Project: Research project
Safety
Therapeutics
Infection Control
Hematopoietic Stem Cells
Placebos
Transplants
Safety
Herpes Zoster Vaccine
Multicenter Studies
Placebos
Safety
Aspergillosis
Biomarkers
Oseltamivir
Amantadine
Ribavirin
Safety
thiazole-4-carboxamide adenine dinucleotide
Pharmacokinetics
posaconazole
Labels
micafungin